Janssen Vaccine Knowledge Assessment

Janssen Vaccine Knowledge Assessment

Assessment

Interactive Video

Science, Biology

9th - 12th Grade

Hard

Created by

Liam Anderson

FREE Resource

The video discusses the FDA's emergency use authorization of the Janssen COVID-19 vaccine, highlighting its 66% effectiveness in preventing moderate to severe cases. Unlike mRNA vaccines, Janssen uses a viral vector to deliver DNA instructions for the spike protein. The vaccine's stability allows for easier storage and distribution, especially in remote areas. It was tested against new variants and may prevent asymptomatic infections, potentially reducing transmission. The video concludes with a sponsor message from Brilliant, encouraging viewers to enhance their STEM skills.

Read more

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What percentage effectiveness did the Janssen vaccine show in preventing moderate to severe COVID-19 cases?

50%

66%

90%

100%

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How does the Janssen vaccine deliver instructions to make the spike protein?

Through mRNA

Through a viral vector with DNA

Through a live attenuated virus

Through a protein subunit

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a key advantage of the Janssen vaccine in terms of storage?

It requires freezing at -70°C

It can be stored at room temperature

It needs to be stored in liquid nitrogen

It can be kept in a fridge for up to three months

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many doses does the Janssen vaccine require?

Two doses

One dose

Three doses

Four doses

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the benefit of having more vaccines available according to the video?

More vaccines mean more options for people to choose from

More vaccines mean longer wait times

More vaccines mean more shots into more arms

More vaccines mean higher costs

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In which countries were the Janssen trials conducted to test its effectiveness against new variants?

India and China

South Africa and Brazil

Australia and New Zealand

United States and Canada

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What potential benefit does the Janssen vaccine have regarding asymptomatic infections?

It may prevent asymptomatic infections with 74% efficacy

It prevents all types of infections

It has no effect on asymptomatic infections

It causes asymptomatic infections

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?